LipexSil

technology

Revolutionize lipid-based delivery systems

About

LipexSil™ lipid technology  provides exclusive access to an  endless array of unique lipids. The proprietary SilBoRed™ technology allows the synthesis of standard lipids, cleaner and less expensive than via currently available synthesis. This technology also gives access to billions of novel lipids with increasing complexities and scalability. The headgroups can be varied for specific cell or tissue targeting. LipexSil™ is the key to lipid-based delivery systems and it is protected by double layer IP.

Originality

A vast and virgin structural space, protected with a double-layer IP.

Effective approach

Analogous and novel lipid tails of increased complexity are available within weeks from in-silico design.

Cost-effective

Fast and inexpensive access to predefined and/or proprietary lipids.

Proven scalability

No special reaction conditions are required, and SilBoRed™ has been proven to be an easy-to-handle reduction technology.

Simplicity

Standard lipids are available, cleaner and less expensive than via the currently available synthesis.

Lipid nanoparticle

A unique solution to one of the most pressing bottlenecks of the pharma industry – delivery of therapeutic oligonucleotides.

Accessibility

Using off-the-shelf and stable building blocks.

Modularity

Billions of novel lipids designed from building blocks accessible only using the SilBoRed™ reduction technology.

Originality

A vast and virgin structural space, protected with a double-layer IP.

Lipid nanoparticle

A unique solution for one of the most pressing bottlenecks of the pharma industry – delivery of RNA drugs and vaccines.

Cost-effective

Fast and inexpensive access to predefined and/or proprietary lipids.

Proven scalability

No special reaction condition are required and SilBoRed has been proven to be easy-to-handle reduction technology.

Effective approach

Analogous and novel lipid tails of increased complexity, within weeks from the in-silico design.

Effective approach

Analogous and novel lipid tails of increased complexity, within weeks from the in-silico design.

Accessibility

Using off-the-shelf stable building blocks.

Modularity

Billions of novel lipids to be designed from building blocks inaccessible to the standard chemical toolbox (Secondary IP).

Application

Have more questions?

Get in touch with us.